Shuichi Aoki

6PUBLICATIONS
32CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 19, 2026
Significance of next-generation sequencing in the era of targeted therapy for biliary tract cancer: an analysis at a single institution.

|Apr 03, 2026
A case of perihilar cholangiocarcinoma with peritoneal dissemination that achieved a pathological complete response using immune checkpoint inhibitors: A case report.

Takehiko Saijo, Hideaki Sato, Shuichi Aoki

|Jan 06, 2026
Characteristics of late recurrences after hepatectomy for perihilar cholangiocarcinoma: a single-center cohort study.

Hideaki Sato, Shuichi Aoki, Masahiro Iseki

|Feb 14, 2025
High preoperative Glasgow prognostic score increases a risk of hospital mortality in elderly patients with perihilar cholangiocarcinoma.

Takashi Kokumai, Shuichi Aoki, Kei Nakagawa

|Jan 23, 2024
Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD-1 Therapy.

Jiang Chen, Zohreh Amoozgar, Xin Liu

Pageof 1

Frequent Collaborators

3 joint publications

Michiaki Unno

2 joint publications

Hideaki Sato

2 joint publications

Kei Nakagawa

1 joint publications

Daisuke Douchi